Latest news
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test - MorningstarMorningstar · Wed, 05 Aug 2026 17:46:00 GMTPAVmed unit Lucid Diagnostics wins Concert commercial coverage policy for EsoGuard test - BitgetBitget · Wed, 05 Aug 2026 16:30:04 GMTLucid's EsoGuard Is the Only Esophageal Precancer Test Meeting Coverage Criteria - Stock TitanStock Titan · Wed, 05 Aug 2026 12:46:00 GMTLucid Diagnostics to Participate in Upcoming Investor Conferences - SahmSahm · Tue, 04 Aug 2026 07:00:00 GMTLucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026 - SahmSahm · Thu, 30 Jul 2026 07:00:00 GMT